An alternative and scalable synthesis for Relugolix

被引：0

作者：

Wang, Xuan ^{[1
]}

Luo, Ying ^{[1
]}

Zhang, Peng ^{[1
]}

Zhu, Xueyan ^{[1
]}

Liu, Xiangkui ^{[1
]}

Chen, Yinbo ^{[1
]}

机构：

[1] Shanghai Inst Pharmaceut Ind Co Ltd, China State Inst Pharmaceut Ind Co Ltd, 285 Gebaini Rd, Shanghai 201203, Peoples R China

来源：

TETRAHEDRON | 2024年 / 167卷

关键词：

Relugolix; New synthetic route; Optimization; Scale up;

D O I：

10.1016/j.tet.2024.134243

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

An alternative and efficient synthetic route for Relugolix was accomplished by changing the construction order of three main parts A, B and C. After the optimization, its scale-up of the preparation for Relogulix was completed in a seven-step methodology with overall yield of 61 % and 99.62 % HPLC purity.

引用

页数：4

共 50 条

[11] Scalable Synthesis of Cyclocitrinol
Wang, Yu
Ju, Wei
Tian, Hailong
Tian, Weisheng
Gui, Jinghan
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (30) : 9413 - 9416
[12] Scalable Synthesis of Mycocyclosin
Zhu, Xu
McAtee, Christopher C.
Schindler, Corinna S.
ORGANIC LETTERS, 2018, 20 (10) : 2862 - 2866
[13] Scalable Synthesis of Cyclotriphenolene
Traore, Tenin
Delacour, Lea
Kotera, Naoko
Merer, Goulven
Buisson, David-Alexandre
Dupont, Christophe
Rousseau, Bernard
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2011, 15 (02) : 435 - 437
[14] Relugolix: First Global Approval
Markham, Anthony
DRUGS, 2019, 79 (06) : 675 - 679
[15] Relugolix in the management of prostate cancer
Sahu, Kamal Kant
Tripathi, Nishita
Agarwal, Neeraj
Swami, Umang
EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (09) : 891 - 902
[16] Relugolix for the treatment of uterine fibroids
Rocca, M. L.
Palumbo, A. R.
Lico, D.
Fiorenza, A.
Bitonti, G.
D'Agostino, S.
Gallo, C.
Di Carlo, C.
Zullo, F.
Venturella, R.
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (14) : 1667 - 1674
[17] Relugolix: First Global Approval
Anthony Markham
Drugs, 2019, 79 : 675 - 679
[18] Relugolix for the treatment of uterine fibroids
Barra, F.
Seca, M.
Della Corte, L.
Giampaolino, P.
Ferrero, S.
DRUGS OF TODAY, 2019, 55 (08) : 503 - 512
[19] Relugolix for the treatment of prostate cancer
Stamatakos, Panagiotis Velissarios
Papavasileiou, Georgios
Leventi, Aggeliki
Papatsoris, Athanasios
Bamias, Aristotelis
Dellis, Athanasios
Fragkoulis, Charalampos
EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (18) : 2399 - 2406
[20] Relugolix, Estradiol, and Norethindrone Acetate
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (19) : 1755 - 1760

← 1 2 3 4 5 →